The Venture Codex Logo

The Venture Codex

Propel Bio Partners

11620 Wilshire Blvd., Suite 350, Los Angeles, CA, 90025, United States

Overview

Private equity firm investing in high-potential biosciences businesses.

Founded

2022

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

United States

Sector focus

—

Investment portfolio

2rounds
NAMEDATESIZE
EIT Pharma
Aug 2026Led
$35 MSeries A
Persephone Biosciences
Jul 2022Led
$15 MSeed
EIT Pharma
Aug 2026Led
$35 MSeries A
Persephone Biosciences
Jul 2022Led
$15 MSeed
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Propel Bio Partners: 2 funding rounds are recorded in the selected participation categories.All available history.
Propel Bio Partners: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A10

Monthly Deal Activity

Propel Bio Partners: 2 deals are recorded across 52 months.All available history.
Propel Bio Partners: 2 deals are recorded across 52 months. All available history
MonthDeals
Jul '221
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

Propel Bio Partners: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Propel Bio Partners: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
AI & Machine Learning1

Deal Size Distribution

Propel Bio Partners: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Propel Bio Partners: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Propel Bio Partners: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Propel Bio Partners: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
Propel Bio Partners: 9 co-investors are shown, with American Cancer Society sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Propel Bio Partners: 9 co-investors are shown, with American Cancer Society sharing 1 recorded deals. All available history
Co-investorShared deals
American Cancer Society1
Arrowtown1
Fifty Years1
First Bight Ventures1
Good Ventures1
Pioneer Fund1
Susa Ventures1
Y Combinator1
ZhenFund1

Investment Strategy

Propel Bio Partners: Led accounts for 100% and participating for 0% of round participation.All available history.
Propel Bio Partners: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led2100%
Participating00%
Propel Bio Partners: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Propel Bio Partners: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Leen Kawas

Co-Founder and Managing Partner

Richard Kayne

Founder at Kayne Anderson Capital